Evidence map›Paper›PMID 37943405›Full record

ArticleAging clinical and experimental research2023

11-beta-hydroxysteroid dehydrogenase type 1 (HSD11B1) gene expression in muscle is linked to reduced skeletal muscle index in sarcopenic patients.

Sabine Schluessel, Wei Zhang, Hanna Nowotny, Martin Bidlingmaier, Stefan Hintze, Sonja Kunz, Sebastian Martini, Stefan Mehaffey, Peter Meinke, Carl Neuerburg and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Aging clinical and experimental research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Context-dependent roles of 11β-HSD1 in bone and skeletal muscle diseases.American journal of translational research · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Sabine SchluesselDepartment of Medicine IV, University Hospital, Ludwig Maximilian University Munich, Ziemssenstraße 5, 80336, Munich, Germany.
Wei ZhangDepartment of Medicine IV, University Hospital, Ludwig Maximilian University Munich, Ziemssenstraße 5, 80336, Munich, Germany.
Hanna NowotnyDepartment of Medicine IV, University Hospital, Ludwig Maximilian University Munich, Ziemssenstraße 5, 80336, Munich, Germany.
Martin BidlingmaierDepartment of Medicine IV, University Hospital, Ludwig Maximilian University Munich, Ziemssenstraße 5, 80336, Munich, Germany.
Stefan HintzeDepartment of Neurology, Friedrich-Baur-Institute, LMU Klinikum, LMU Munich, Munich, Germany.
Sonja KunzDepartment of Medicine IV, University Hospital, Ludwig Maximilian University Munich, Ziemssenstraße 5, 80336, Munich, Germany.
Sebastian MartiniDepartment of Medicine IV, University Hospital, Ludwig Maximilian University Munich, Ziemssenstraße 5, 80336, Munich, Germany.
Stefan MehaffeyDepartment of Orthopaedics and Trauma Surgery, Musculoskeletal University Center Munich (MUM), University Hospital, LMU Munich, Munich, Germany.
Peter MeinkeDepartment of Neurology, Friedrich-Baur-Institute, LMU Klinikum, LMU Munich, Munich, Germany.
Carl NeuerburgDepartment of Orthopaedics and Trauma Surgery, Musculoskeletal University Center Munich (MUM), University Hospital, LMU Munich, Munich, Germany.
Ralf SchmidmaierDepartment of Medicine IV, University Hospital, Ludwig Maximilian University Munich, Ziemssenstraße 5, 80336, Munich, Germany.
Benedikt SchoserDepartment of Neurology, Friedrich-Baur-Institute, LMU Klinikum, LMU Munich, Munich, Germany.
Nicole ReischDepartment of Medicine IV, University Hospital, Ludwig Maximilian University Munich, Ziemssenstraße 5, 80336, Munich, Germany. Nicole.reisch@med.uni-muenchen.de.
Michael DreyDepartment of Medicine IV, University Hospital, Ludwig Maximilian University Munich, Ziemssenstraße 5, 80336, Munich, Germany.
Ludwig-Maximilians-Universität München · DELMU Klinikum · DE

Funding

Clinician Scientist Program RISE 2019_KollegSE.03Deutsche Forschungsgemeinschaft 314061271-TRR 205Deutsche Forschungsgemeinschaft 325768017FöFole 1148H2020 European Research Council 721577
6 · The paper itself

Abstract

backgroundGlucocorticoids play a significant role in metabolic processes and pathways that impact muscle size, mass, and function. The expression of 11-beta-hydroxysteroid dehydrogenase type 1 (HSD11B1) has been previously described as a major regulator of skeletal muscle function in glucocorticoid-induced muscle atrophy and aging humans. Our study aimed to investigate glucocorticoid metabolism, including the expression of HSD11B1 in skeletal muscle, in patients with sarcopenia.

methodsMuscle biopsies were taken from the vastus lateralis muscle of thirty-three patients over 60 years of age with hip fractures. Sarcopenia status was assessed according to the criteria of the European Working Group on Sarcopenia in Older People 2. Skeletal muscle mass was measured by bioelectrical impedance analysis. Cortisol and cortisone concentrations were measured in serum. Gene expression analysis of HSD11B1, NR3C1, FBXO32, and TRIM63 in muscle biopsies was performed. Serial cross sections of skeletal muscle were labeled with myosin heavy chain slow (fiber type-1) and fast (fiber type-2) antibodies.

resultsThe study included 33 patients (21 women) with a mean age of 82.5 ± 6.3 years, 17 patients revealed sarcopenic (n = 16 non-sarcopenic). Serum cortisone concentrations were negatively correlated with muscle mass (ß =  - 0.425; p = 0.034) and type-2 fiber diameter (ß =  - 0.591; p = 0.003). Gene expression of HSD11B1 (ß =  - 0.673; p = 0.008) showed a negative correlation with muscle mass in the sarcopenic group. A significant correlation was found for the non-sarcopenic group for NR3C1 (ß = 0.548; p = 0.028) and muscle mass.

conclusionThese findings suggest a pathogenetic role of HSD11B1 in sarcopenic muscle.

Indexed as

11-beta-Hydroxysteroid Dehydrogenase Type 1CortisoneSarcopeniaAgedAged, 80 and overFemaleGene ExpressionGlucocorticoidsHumansMiddle AgedMuscle, Skeletal11-beta-Hydroxysteroid Dehydrogenase Type 1CortisoneGlucocorticoidsHSD11B1 protein, humanFBXO32GlucocorticoidsHSD11B1NR3C1SarcopeniaTRIM63

Identifiers

PMID37943405
PMCPMC10721692
OpenAlexW4388539466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.